eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
3/2017
vol. 9
 
Share:
Send email
Share:
abstract:
Case report

Use of high doses of oxycodone-naloxone combination in the treatment of pain in patients with advanced cancer suffering from opioid bowel dysfunction (OBD) – case reports

Łukasz Pietrzyński
,
Mateusz Rajchel
,
Tatiana Pietrzyńska

Online publish date: 2018/02/01
View full text Get citation
 
Introduction: Long-term opioid therapy for severe, chronic cancer pain is associated with a number of side effects. One of the most common is opioid bowel dysfunction (OBD). In this article, the authors present one of the options for treatment of this adverse effect by a combination of opioid analgesic formulation and opioid receptor antagonist (oxycodone and naloxone).

Case reports: The authors present reports of two patients suffering from bowel dysfunction due to long-term, high-dose, opioid chronic cancer-pain treatment. In both cases, strong opioid pharmacotherapy was changed to treatment with a combination of oxycodone and naloxone controlled-release tablets. It resulted in reduction of opioid bowel dysfunction symptoms and an increase in patient’s quality of life.

Conclusions: The presented cases illustrate the efficacy of high-dose oxycodone-naloxone combination therapy in reducing opioid bowel dysfunction while maintaining effective analgesia and good toleration of treatment.
keywords:

oxycodone, naloxone, chronic pain, constipation
FEATURED PRODUCTS
BOOKS
• Medycyna Paliatywna
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.